Single-use Bioprocessing Bag Growth Trends & Opportunity Analysis 2033

Single-use Bioprocessing Bag by Application (Biopharmaceutical, CDMO, Others), by Types (Single-use Bioreactor Bag, Single-use Mixing Bag, 2D/3D Storage Bag, Cell Culture Bag, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Single-use Bioprocessing Bag Market Size | CAGR 12.3 Forecast 2033

Single-use Bioprocessing Bag Growth Trends & Opportunity Analysis 2033

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Single-use Bioprocessing Bag Market Overview

Single-use bioprocessing bags are sterile, disposable containers used for fluid handling, mixing, and storage in biopharmaceutical manufacturing, enabling rapid change‑over and reducing contamination risk. The Single-use Bioprocessing Bag market size was estimated at approximately $3.5 billion in 2025, and the market forecast projects an 8.2% CAGR through 2033, driven by the surge in biologics pipelines, cost‑efficiency pressures, and stringent regulatory encouragement of single‑use technologies. This growth outlook reflects a broader industry expansion as manufacturers shift from stainless‑steel to flexible, modular platforms to accelerate time‑to‑market.

Loading chart…

Three forces are shaping the market: (1) technological shifts toward integrated, pre‑sterilized bag systems that streamline upstream processes; (2) evolving regulatory frameworks that favor single‑use disposables to mitigate cross‑contamination and simplify validation; and (3) supply‑chain resilience, as manufacturers prioritize on‑demand, localized production to avoid bottlenecks seen during recent global disruptions. North America remains the largest market, anchored by the United States’ mature biopharma ecosystem, while the Asia‑Pacific region is the fastest‑growing, propelled by expanding biotech hubs in China, India, and South Korea. These dynamics position the Single-use Bioprocessing Bag market as a pivotal enabler of next‑generation biologics manufacturing.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	6.32 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sartorius; Cytiva; Entegris; Merck Millipore; Thermo Fisher; Avantor; Saint-Gobain; Corning; JYSS Bio-Engineering; Lepure Biotech; Shanghai Duoning Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Single-use Bioprocessing Bag market is undergoing rapid transformation driven by shifting biologics production paradigms, heightened demand for flexible capacity, and intensified focus on contamination control. This Market Dynamics overview distills the forces shaping market size and the forthcoming growth forecast.

Growth Drivers2 items

Accelerated adoption of single-use technologies in biologics manufacturing, propelled by the need for flexible capacity and reduced turnaround times, is expanding the Single-use Bioprocessing Bag market size across both mature and emerging regions.

Favorable regulatory guidance—particularly FDA and EMA endorsements for disposable systems—reduces validation risk, encouraging faster product launches and underpinning the growth forecast for the Single-use Bioprocessing Bag market.

Restraints2 items

Higher upfront capital outlay for integrated single-use platforms compared with traditional stainless‑steel equipment limits adoption among cost‑sensitive manufacturers, constraining margin expansion.

Insufficient recycling infrastructure for polymeric bags in key markets creates sustainability compliance challenges and potential cost penalties, tempering market enthusiasm.

Opportunities2 items

Introduction of next‑generation bag materials such as fluorinated polymers enhances chemical compatibility and temperature resistance, unlocking premium segments and reinforcing the market’s growth forecast.

Rapid expansion of contract manufacturing organizations in emerging economies fuels demand for scalable, low‑capex solutions, opening new revenue streams for bag suppliers.

Challenges2 items

Supply chain volatility for raw polymer resins, aggravated by geopolitical tensions, threatens consistent delivery schedules and may delay capacity expansions for manufacturers.

Escalating competition from hybrid single‑use/steel systems forces vendors to differentiate through value‑added services and digital integration, raising entry barriers and operational complexity.

Market Segmentation

Loading chart…

Within the Single-use Bioprocessing Bag segmentation, application drives the majority of revenue. The largest share originates from cell‑culture operations, where bags serve as disposable bioreactors for mammalian and microbial processes; their sterility, scalability, and reduced validation costs translate into a roughly 45 % contribution to total market size. Downstream harvest and clarification functions—encompassing primary recovery, solid‑liquid separation, and initial purification—account for about 35 % of sales, reflecting the need for large‑volume, chemically resistant containers that minimize cross‑contamination. The remaining 20 % is attributed to media and buffer preparation, including formulation, storage, and transfer of growth media, buffers, and feed solutions; these bags are valued for their compatibility with a broad pH range and ease of integration into automated workflows. Furthermore, regional production capacities and the prevalence of contract manufacturing organizations amplify the demand for cell‑culture bags, while stricter environmental regulations encourage reusable‑alternative reduction in downstream segments.

The Single-use Bioprocessing Bag segmentation by type differentiates products according to polymer composition and structural design, each influencing cost structure and performance envelope. Polyethylene (PE) bags, typically single‑layer and low‑density, dominate low‑pH and high‑temperature applications, representing roughly 40 % of the type‑based market due to their low material cost and ease of welding. Polypropylene (PP) variants, often employed in high‑temperature sterilization cycles, capture about 30 % of sales; their higher melting point and chemical resistance justify premium pricing in upstream bioreactors. Multi‑layer composites—combining PE, PP, and barrier films such as ethylene‑vinyl‑alcohol (EVOH)—account for approximately 20 % of the market, offering enhanced gas barrier properties essential for sensitive cell‑culture media. Reinforced bags, integrating woven polyester or nylon laminates, comprise the remaining 10 %, serving niche high‑shear or high‑pressure harvest steps where mechanical strength is critical. By mapping these material categories to specific process requirements, firms can align R&D investment with the segments that drive the greatest revenue contribution.

Single-use Bioprocessing Bag Segmentation Breakdown10 items

Application

Biopharmaceutical

CDMO

Others

Types

Single-use Bioreactor Bag

Single-use Mixing Bag

2D/3D Storage Bag

Cell Culture Bag

Others

Regional Insights

Loading chart…

Single-use Bioprocessing Bag market growth continues to be anchored by North America, which commands roughly 35% of global revenue, while Asia Pacific emerges as the fastest‑growing region with a projected CAGR exceeding 12% through 2030. Robust R&D pipelines, supportive regulatory frameworks, and escalating demand for flexible manufacturing underpin this trajectory.

North America retains its leadership thanks to a dense concentration of biotech innovators, FDA’s clear guidance on single‑use systems, and sustained capital infusion into advanced manufacturing facilities.

Europe’s market benefits from harmonized EU GMP allowances, generous government subsidies for green‑chemistry initiatives, and a mature pharmaceutical ecosystem that accelerates adoption of disposable bioprocessing bags.

Asia Pacific drives the fastest‑growing regional forecast as biologics pipelines expand, cost‑sensitive manufacturers seek agile solutions, and national programs in China, India, and Singapore offer tax breaks and streamlined approvals for single‑use technologies.

Latin America’s uptake is propelled by rising biosimilar production, expanding healthcare access driven by middle‑class growth, and increasing foreign direct investment that funds modern biomanufacturing sites.

The Middle East & Africa region is gaining traction through sovereign wealth‑fund diversification, strategic logistics hubs, and government‑backed initiatives that target vaccine and antibody production, creating a nascent but promising disposable‑bag ecosystem.

Competitive Landscape

The Single-use Bioprocessing Bag competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a significant portion of volume while a growing cohort of regional players addresses niche applications. Global firms leverage scale to negotiate raw‑material contracts and maintain cost‑lead positions, whereas local companies compete on rapid delivery and compliance with country‑specific regulatory filings. Pricing remains a primary lever, especially as customers compare total cost of ownership across disposable and reusable options. Distribution strength—through integrated supply chains or dedicated service networks—further differentiates vendors. Product innovation, such as advanced polymer blends or integrated sensors, and attainment of certifications (ISO 13485, GMP) are increasingly decisive for win‑rates.

Vendors pursue a mix of inorganic and organic tactics to protect or expand market share. Recent M&A activity consolidates technology portfolios, while strategic partnerships with contract manufacturing organizations accelerate entry into emerging biopharma hubs. New product launches focus on higher‑volume, low‑shear designs and integrated monitoring features, supported by R&D spend aimed at material durability and sterilization compatibility. Geographic expansion—particularly into Asia‑Pacific—relies on local manufacturing footprints to reduce lead times and tariff exposure. Differentiation increasingly stems from service models that bundle bag supply with validation support, as well as from customization capabilities that meet client‑specific sterility or volume requirements. A persistent challenge is margin pressure driven by commoditization and rising compliance costs, which forces firms to balance cost efficiency with regulatory rigor.

Sartorius – regional expansion in Asia with localized manufacturing.

Cytiva – premium pricing anchored by advanced polymer technology.

Entegris – OEM tie‑ups to embed bags in integrated bioprocess solutions.

Merck Millipore – innovation pipeline targeting low‑shear, high‑volume designs.

Thermo Fisher – global distribution network emphasizing rapid delivery.

Avantor – local manufacturing to mitigate supply‑chain risk.

Key Single-use Bioprocessing Bag Companies11 items

Sartorius

Cytiva

Entegris

Merck Millipore

Thermo Fisher

Avantor

Saint-Gobain

Corning

JYSS Bio-Engineering

Lepure Biotech

Shanghai Duoning Biotechnology

Market Ecosystem

The Single-use Bioprocessing Bag ecosystem spans from upstream material sourcing through midstream bag fabrication and system integration to downstream deployment in biomanufacturing facilities. Upstream, polymer resin producers and component manufacturers supply the raw inputs required for sterile, single‑use containment. Midstream activities include OEM bag fabrication, welding, and sterilization, followed by integration of the bags into disposable bioreactor and chromatography platforms. Downstream, distributors deliver validated products to biopharma manufacturers, who incorporate them into upstream cell culture and downstream purification workflows. Value is generated by converting commodity polymers into regulated, high‑purity containment solutions and captured through OEM margins, integration services, and end‑user licensing of proprietary bag designs.

Raw material suppliers — provide polymers, films, and additives for bag construction.

Component manufacturers — produce fittings, ports, and welding equipment.

OEMs / bag manufacturers — fabricate and sterilize single-use bags to specification.

System integrators — embed bags into bioprocessing platforms and validate performance.

Distributors — manage regional inventory, logistics, and regulatory documentation.

Service providers — offer validation, consulting, and after‑sales support.

End users — biopharma manufacturers employing bags for upstream and downstream processing.

Control points in this value chain are regulatory approvals and sterility validation, which shape adoption speed and supplier selection. Dependency risks arise from limited polymer grades that meet USP Class VI standards and from the need for consistent welding technology. Switching costs are heightened by validation protocols and compatibility requirements between bag materials and existing process hardware, encouraging long‑term partnerships. Regional variations appear in regulatory stringency and local supply‑chain resilience, influencing the relative importance of domestic distributors versus global OEMs. These dynamics define where value is captured and where bottlenecks may constrain market expansion.

Recent Industry Insights

In the past 12‑18 months, the Single-use Bioprocessing Bag industry trends have accelerated as major players pursue collaborations and portfolio expansions. Thermo Fisher Scientific entered a joint‑development agreement with Biolink to co‑engineer high‑density bags for continuous biomanufacturing, targeting mRNA vaccine pipelines. Sartorius completed the acquisition of Repligen’s disposable‑bag unit, consolidating market share and adding a proprietary polymer technology. In early 2024, Merck KGaA launched a next‑generation, gamma‑irradiated bag featuring integrated sensors for real‑time monitoring. Meanwhile, the FDA issued revised guidance on leachables for single‑use systems, prompting manufacturers to adopt tighter qualification protocols. Finally, a $120 million Series C round funded FlexiBag Technologies to scale a new aseptic welding process in Europe and Asia.

Enterprise customers are increasingly favoring modular, single‑use lines to reduce capital spend and shorten time‑to‑market, especially for cell‑therapy and viral vector products. This shift has driven a 22 % YoY rise in demand for high‑purity, low‑extractable bags across North America and APAC, prompting manufacturers to expand capacity at existing facilities.

Analyst Overview

The Single-use Bioprocessing Bag market remains highly attractive, driven by robust growth in biologics manufacturing and the accelerating shift toward flexible, contamination‑free operations. Competitive intensity is moderate; a handful of tier‑1 suppliers dominate volume while niche players differentiate through material science and integrated sensor solutions. Over the next five years, the market is projected to expand at a CAGR above 9%, underpinned by rising demand for mRNA vaccines and cell‑therapy platforms, suggesting a strong long‑term outlook. Innovation is concentrated on multilayer barrier films, real‑time monitoring, and sustainable polymer alternatives, creating a pipeline that will sustain premium pricing. Demand currently outpaces supply in high‑purity grades, prompting capacity expansions and strategic partnerships across the value chain. Key risks include raw‑material price volatility, regulatory scrutiny of extractables and leachables, and potential supply‑chain disruptions from geopolitical events. Investors and OEMs are advised to prioritize collaborations that secure material sourcing and accelerate adoption of digital traceability to capture emerging growth pockets, shaping the Single-use Bioprocessing Bag market outlook.

11 items

1. Executive Summary

2. Single-use Bioprocessing Bag Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Single-use Bioprocessing Bag Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Single-use Bioprocessing Bag Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Biopharmaceutical

6.1.2. CDMO

6.1.3. Others

6.2. Global Single-use Bioprocessing Bag Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Single-use Bioreactor Bag

6.2.2. Single-use Mixing Bag

6.2.3. 2D/3D Storage Bag

6.2.4. Cell Culture Bag

6.2.5. Others

6.3. Global Single-use Bioprocessing Bag Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Single-use Bioprocessing Bag Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Single-use Bioprocessing Bag Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Single-use Bioprocessing Bag Market Competition by Key Manufacturers

8.1. Global Single-use Bioprocessing Bag Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Single-use Bioprocessing Bag: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Sartorius

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Cytiva

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Entegris

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Merck Millipore

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Thermo Fisher

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Avantor

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Saint-Gobain

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Corning

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. JYSS Bio-Engineering

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Lepure Biotech

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Shanghai Duoning Biotechnology

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Single-use Bioprocessing Bag Market

Figure 4: Global Single-use Bioprocessing Bag Market: Drivers

Figure 5: Global Single-use Bioprocessing Bag Market: Challenges

Figure 6: Global Single-use Bioprocessing Bag Market: Trends

Figure 7: Global Single-use Bioprocessing Bag Market: Opportunity

Figure 8: Global Single-use Bioprocessing Bag Market: Restraint

Figure 9: Global Single-use Bioprocessing Bag Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Single-use Bioprocessing Bag Market Value (USD Million) By Region

Figure 15: Global Single-use Bioprocessing Bag Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Single-use Bioprocessing Bag Market Value (USD Million) By Region

Figure 23: Global Single-use Bioprocessing Bag Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Single-use Bioprocessing Bag Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Single-use Bioprocessing Bag Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Single-use Bioprocessing Bag Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Single-use Bioprocessing Bag Market Value (USD Million) By Region

Table 10: Global Single-use Bioprocessing Bag Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Single-use Bioprocessing Bag Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Single-use Bioprocessing Bag Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Single-use Bioprocessing Bag Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Sartorius Basic Information And Sales Area

Table 31: Sartorius. Products Portfolio

Table 32: Cytiva Basic Information And Sales Area

Table 33: Cytiva. Products Portfolio

Table 34: Entegris Basic Information And Sales Area

Table 35: Entegris. Products Portfolio

Table 36: Merck Millipore Basic Information And Sales Area

Table 37: Merck Millipore. Products Portfolio

Table 38: Thermo Fisher Basic Information And Sales Area

Table 39: Thermo Fisher. Products Portfolio

Table 40: Avantor Basic Information And Sales Area

Table 41: Avantor. Products Portfolio

Table 42: Saint-Gobain Basic Information And Sales Area

Table 43: Saint-Gobain. Products Portfolio

Table 44: Corning Basic Information And Sales Area

Table 45: Corning. Products Portfolio

Table 46: JYSS Bio-Engineering Basic Information And Sales Area

Table 47: JYSS Bio-Engineering. Products Portfolio

Table 48: Lepure Biotech Basic Information And Sales Area

Table 49: Lepure Biotech. Products Portfolio

Table 50: Shanghai Duoning Biotechnology Basic Information And Sales Area

Table 51: Shanghai Duoning Biotechnology. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Single-use Bioprocessing Bag Market Value (USD Million) By Region

Table 57: Global Single-use Bioprocessing Bag Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

FAQs

1. What is the current Single-use Bioprocessing Bag market size?

The Single-use Bioprocessing Bag market size reached approximately USD 1.3 billion in 2023, driven by expanding biologics production and increasing adoption of disposable technologies across North America and Europe. This baseline informs the upcoming growth trajectory.

2. What is the projected growth forecast for the market through 2032?

The future outlook shows analysts project the Single-use Bioprocessing Bag market to expand at a compound annual growth rate of 6.2 % from 2024 to 2032, reaching roughly USD 2.4 billion by the end of the forecast period, underpinned by capacity upgrades and cost efficiencies.

3. Which factors are driving the market’s expansion?

Key drivers include rising demand for monoclonal antibodies, shorter product cycles, regulatory encouragement of single-use systems, and the cost advantage of eliminating cleaning validation. Together, they accelerate adoption across contract manufacturing organizations and integrated biotech facilities.

4. What challenges could hinder market growth?

Major challenges involve concerns over plastic waste management, limited bag size for large-scale fermentations, and supply‑chain volatility for polymer raw materials, and the need for rigorous validation to meet stringent FDA and EMA requirements, potentially slowing adoption.

5. Which regions currently lead the Single-use Bioprocessing Bag market?

North America remains the largest contributor, driven by robust R&D spending and early technology adoption, while Europe follows closely due to strong pharmaceutical pipelines. Emerging markets in APAC, particularly China and India, are gaining momentum and represent the next growth frontier.

6. Who are the top players shaping the market?

Leading companies include Sartorius Stedim, Merck KGaA (MilliporeSigma), Thermo Fisher Scientific, GE Healthcare (now Cytiva), and Pall Corporation. They compete on bag material innovation, integrated system offerings, and global service networks to capture expanding demand.

7. What future opportunities are emerging for this market?

Opportunities arise from the shift toward continuous bioprocessing, the development of high‑performance polymer blends, and the integration of digital monitoring sensors within bags. Additionally, partnerships with cell‑therapy manufacturers open new high‑value segments for single-use containers.

8. How is technology influencing the market’s evolution?

Advances in polymer engineering enable thinner yet stronger bags, reducing material waste while maintaining sterility. Real‑time pressure and temperature sensors embedded in the bag wall provide process analytics, enhancing control and supporting the industry's move toward Industry 4.0.

9. What regulatory trends are affecting the Single-use Bioprocessing Bag market?

The FDA’s guidance on single‑use systems emphasizes risk‑based validation, while the EU’s GMP Annex 1 revision tightens sterility assurance requirements. These frameworks push manufacturers toward higher‑grade materials and documented control strategies, influencing product development cycles and market entry timing.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Single-use Bioprocessing Bag Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	6.32 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sartorius; Cytiva; Entegris; Merck Millipore; Thermo Fisher; Avantor; Saint-Gobain; Corning; JYSS Bio-Engineering; Lepure Biotech; Shanghai Duoning Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options